Coherus BioSciences Inc. (CHRS)
1.00
-0.00 (-0.50%)
At close: Mar 04, 2025, 1:04 PM
Coherus BioSciences Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 102.89M | 63.55M | 417.19M | 541.16M | 177.67M | 72.36M | 126.91M | 124.95M | 158.23M | 150.39M | 39.55M | 14.55M |
| Short-Term Investments | 14.86M | 128.13M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | 440K | 440K | 440K | 240K | 785K | 785K | 785K | 785K | n/a | n/a | n/a |
| Other Long-Term Assets | 71.27M | 49.47M | 34.49M | 27.63M | 14.14M | 16.89M | 19.36M | 39.2M | 40.09M | 28.79M | 27K | 129K |
| Receivables | 260.52M | 109.96M | 123.02M | 157.05M | 141.99M | n/a | n/a | 1.86M | 1.56M | 4.23M | 385K | 158K |
| Inventory | 62.6M | 115.05M | 93.25M | 92.19M | 55.07M | 1.66M | n/a | -4.84M | -4.36M | -8.2M | 1.00 | 10.03M |
| Other Current Assets | 34.76M | 40.8M | 24.46M | 25.04M | 13.54M | 10.42M | 18.57M | 34.68M | 37.6M | 24.51M | 5.74M | 10.09M |
| Total Current Assets | 475.63M | 416.7M | 633.47M | 790.39M | 374.73M | 72.36M | 126.91M | 124.95M | 158.23M | 150.39M | 45.68M | 24.8M |
| Property-Plant & Equipment | 11.03M | 8.75M | 7.81M | 20.06M | 16.49M | 6.66M | 12.77M | 10.77M | 10.5M | 4.47M | 1.74M | 1.6M |
| Goodwill & Intangibles | 71.67M | 5.93M | 3.56M | 3.56M | 3.56M | 3.56M | 3.56M | 3.56M | 3.56M | 3.56M | n/a | n/a |
| Total Long-Term Assets | 153.97M | 64.15M | 45.87M | 51.26M | 34.2M | 27.11M | 35.7M | 53.54M | 54.16M | 36.83M | 1.77M | 1.73M |
| Total Assets | 629.6M | 480.85M | 679.33M | 841.65M | 408.93M | 99.47M | 162.61M | 178.49M | 212.38M | 187.22M | 47.45M | 26.53M |
| Account Payables | 35.22M | 11.53M | 16.16M | 15.2M | 25.98M | 15.29M | 15.71M | 20.58M | 29.5M | 10.8M | 3.69M | 3.9M |
| Deferred Revenue | n/a | n/a | n/a | -3.13M | -2.2M | n/a | 8.82M | 1.96M | 50.95M | 23.99M | 14.28M | 2.02M |
| Short-Term Debt | 2.15M | 4.32M | 3.49M | 3.13M | 2.2M | n/a | n/a | n/a | n/a | n/a | 4.2M | 1.74M |
| Other Current Liabilities | 294.41M | 122.85M | 145.68M | 127.32M | 86.79M | 17.97M | 12.68M | 33.83M | 25.57M | 40.98M | 31.53M | 3.59M |
| Total Current Liabilities | 331.77M | 54.46M | 79.03M | 81.53M | 114.97M | 33.26M | 28.39M | 56.38M | 106.02M | 51.78M | 53.7M | 11.25M |
| Long-Term Debt | 478.7M | 476.1M | 415.53M | 413.97M | 188.64M | 103.09M | 101.61M | 100.26M | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | 11.46M | 3.47M | 750K | 1.05M | 102K | 1.71M | 2.07M | 1.83M | 67.96M | 28.78M | 7.56M | 12K |
| Total Long-Term Liabilities | 491.26M | 563.8M | 502.58M | 479.15M | 303.71M | 138.06M | 132.08M | 159.13M | 219.31M | 120.46M | 36.13M | 6.09M |
| Total Liabilities | 823.03M | 618.26M | 581.61M | 560.67M | 303.71M | 138.06M | 132.08M | 159.13M | 219.31M | 120.46M | 89.83M | 17.34M |
| Total Debt | 480.84M | 471.06M | 408.28M | 404.02M | 178.39M | 103.09M | 101.41M | 100.26M | n/a | n/a | 4.2M | 1.74M |
| Common Stock | 11K | 8K | 7K | 7K | 7K | 7K | 6K | 5K | 4K | 3K | 1K | 1K |
| Retained Earnings | -1.58B | -1.34B | -1.05B | -762.75M | -895M | -984.83M | -775.49M | -537.32M | -409.99M | -186.72M | -99.59M | -45.96M |
| Comprehensive Income | -248K | -249K | -270K | -270K | -558K | -282K | -750K | -630K | -401K | -525K | -625K | -226K |
| Shareholders Equity | -193.43M | -137.42M | 97.73M | 280.97M | 105.21M | -38.59M | 30.54M | 19.35M | -6.93M | 66.76M | -42.38M | 9.19M |
| Total Investments | 14.86M | 128.13M | 440K | 440K | 240K | 785K | 785K | 785K | 785K | n/a | n/a | n/a |